Docetaxel-based CRT improves survival in cisplatin-ineligible patients
Crossref DOI link: https://doi.org/10.1038/s41571-023-00740-7
Published Online: 2023-02-10
Published Print: 2023-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Killock, David
Text and Data Mining valid from 2023-02-10
Version of Record valid from 2023-02-10
Article History
First Online: 10 February 2023